MSK1 and MSK2 Inhibit Lipopolysaccharide-Induced Prostaglandin Production via an Interleukin-10 Feedback Loop

REFERENCES

• Marnett LJ. 2009. The COXIB experience: a look in the rearview mirror. Annu. Rev. Pharmacol. Toxicol. 49:265–290.
   PubMed Web of Science ®Google Scholar
• Matsuoka T, Narumiya S. 2007. Prostaglandin receptor signaling in disease. ScientificWorldJournal 7:1329–1347.
   PubMedGoogle Scholar
• Smith WL, DeWitt DL, Garavito RM. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69:145–182.
   PubMed Web of Science ®Google Scholar
• Rajakariar R, Yaqoob MM, Gilroy DW. 2006. COX-2 in inflammation and resolution. Mol. Interv. 6:199–207.
   PubMedGoogle Scholar
• Kang YJ, Mbonye UR, DeLong CJ, Wada M, Smith WL. 2007. Regulation of intracellular cyclooxygenase levels by gene transcription and protein degradation. Prog. Lipid Res. 46:108–125.
   PubMed Web of Science ®Google Scholar
• Harper KA, Tyson-Capper AJ. 2008. Complexity of COX-2 gene regulation. Biochem. Soc. Trans. 36:543–545.
   PubMed Web of Science ®Google Scholar
• Paul A, Cuenda A, Bryant CE, Murray J, Chilvers ER, Cohen P, Gould GW, Plevin R. 1999. Involvement of mitogen-activated protein kinase homologues in the regulation of lipopolysaccharide-mediated induction of cyclo-oxygenase-2 but not nitric oxide synthase in RAW 264.7 macrophages. Cell. Signal. 11:491–497.
   PubMed Web of Science ®Google Scholar
• Dean JL, Brook M, Clark AR, Saklatvala J. 1999. p38 mitogen-activated protein kinase regulates cyclooxygenase-2 mRNA stability and transcription in lipopolysaccharide-treated human monocytes. J. Biol. Chem. 274:264–269.
   PubMed Web of Science ®Google Scholar
• Caivano M, Cohen P. 2000. Role of mitogen-activated protein kinase cascades in mediating lipopolysaccharide-stimulated induction of cyclooxygenase-2 and IL-1 beta in RAW264 macrophages. J. Immunol. 164:3018–3025.
   PubMed Web of Science ®Google Scholar
• Eliopoulos AG, Dumitru CD, Wang CC, Cho J, Tsichlis PN. 2002. Induction of COX-2 by LPS in macrophages is regulated by Tpl2-dependent CREB activation signals. EMBO J. 21:4831–4840.
   PubMed Web of Science ®Google Scholar
• Caivano M, Gorgoni B, Cohen P, Poli V. 2001. The induction of cyclooxygenase-2 mRNA in macrophages is biphasic and requires both CCAAT enhancer-binding protein beta (C/EBP beta) and C/EBP delta transcription factors. J. Biol. Chem. 276:48693–48701.
   PubMedGoogle Scholar
• Wadleigh DJ, Reddy ST, Kopp E, Ghosh S, Herschman HR. 2000. Transcriptional activation of the cyclooxygenase-2 gene in endotoxin-treated RAW 264.7 macrophages. J. Biol. Chem. 275:6259–6266.
   PubMed Web of Science ®Google Scholar
• Park SW, Sung MW, Heo DS, Inoue H, Shim SH, Kim KH. 2005. Nitric oxide upregulates the cyclooxygenase-2 expression through the cAMP-response element in its promoter in several cancer cell lines. Oncogene 24:6689–6698.
   PubMedGoogle Scholar
• Chen LC, Chen BK, Chang WC. 2005. Activating protein 1-mediated cyclooxygenase-2 expression is independent of N-terminal phosphorylation of c-Jun. Mol. Pharmacol. 67:2057–2069.
   PubMedGoogle Scholar
• Kang YJ, Wingerd BA, Arakawa T, Smith WL. 2006. Cyclooxygenase-2 gene transcription in a macrophage model of inflammation. J. Immunol. 177:8111–8122.
   PubMed Web of Science ®Google Scholar
• Cardinaux JR, Notis JC, Zhang Q, Vo N, Craig JC, Fass DM, Brennan RG, Goodman RH. 2000. Recruitment of CREB binding protein is sufficient for CREB-mediated gene activation. Mol. Cell. Biol. 20:1546–1552.
   PubMed Web of Science ®Google Scholar
• Mayr B, Montminy M. 2001. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. 2:599–609.
   PubMed Web of Science ®Google Scholar
• Gonzalez GA, Montminy MR. 1989. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59:675–680.
   PubMed Web of Science ®Google Scholar
• Chrivia JC, Kwok RP, Lamb N, Hagiwara M, Montminy MR, Goodman RH. 1993. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature 365:855–859.
   PubMed Web of Science ®Google Scholar
• Park JM, Greten FR, Wong A, Westrick RJ, Arthur JS, Otsu K, Hoffmann A, Montminy M, Karin M. 2005. Signaling pathways and genes that inhibit pathogen-induced macrophage apoptosis—CREB and NF-kappaB as key regulators. Immunity 23:319–329.
   PubMed Web of Science ®Google Scholar
• Ananieva O, Darragh J, Johansen C, Carr JM, McIlrath J, Park JM, Wingate A, Monk CE, Toth R, Santos SG, Iversen L, Arthur JS. 2008. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat. Immunol. 9:1028–1036.
   PubMed Web of Science ®Google Scholar
• McCoy CE, Macdonald A, Morrice NA, Campbell DG, Deak M, Toth R, McIlrath J, Arthur JS. 2007. Identification of novel phosphorylation sites in MSK1 by precursor ion scanning MS. Biochem. J. 402:491–501.
   Google Scholar
• McCoy CE, Campbell DG, Deak M, Bloomberg GB, Arthur JS. 2005. MSK1 activity is controlled by multiple phosphorylation sites. Biochem. J. 387:507–517.
   PubMed Web of Science ®Google Scholar
• Deak M, Clifton AD, Lucocq LM, Alessi DR. 1998. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK2/p38, and may mediate activation of CREB. EMBO J. 17:4426–4441.
   PubMed Web of Science ®Google Scholar
• Pathak SK, Bhattacharyya A, Pathak S, Basak C, Mandal D, Kundu M, Basu J. 2004. Toll-like receptor 2 and mitogen- and stress-activated kinase 1 are effectors of Mycobacterium avium-induced cyclooxygenase-2 expression in macrophages. J. Biol. Chem. 279:55127–55136.
   PubMedGoogle Scholar
• Grishin AV, Wang J, Potoka DA, Hackam DJ, Upperman JS, Boyle P, Zamora R, Ford HR. 2006. Lipopolysaccharide induces cyclooxygenase-2 in intestinal epithelium via a noncanonical p38 MAPK pathway. J. Immunol. 176:580–588.
   PubMedGoogle Scholar
• Bain J, Plater L, Elliott M, Shpiro N, Hastie CJ, McLauchlan H, Klevernic I, Arthur JS, Alessi DR, Cohen P. 2007. The selectivity of protein kinase inhibitors: a further update. Biochem. J. 408:297–315.
   PubMed Web of Science ®Google Scholar
• Wiggin GR, Soloaga A, Foster JM, Murray-Tait V, Cohen P, Arthur JS. 2002. MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol. Cell. Biol. 22:2871–2881.
   PubMed Web of Science ®Google Scholar
• Darragh J, Ananieva O, Courtney A, Elcombe S, Arthur JS. 2010. MSK1 regulates the transcription of IL-1ra in response to TLR activation in macrophages. Biochem. J. 425:595–602.
   PubMedGoogle Scholar
• Kim C, Sano Y, Todorova K, Carlson BA, Arpa L, Celada A, Lawrence T, Otsu K, Brissette JL, Arthur JS, Park JM. 2008. The kinase p38 alpha serves cell type-specific inflammatory functions in skin injury and coordinates pro- and anti-inflammatory gene expression. Nat. Immunol. 9:1019–1027.
   PubMed Web of Science ®Google Scholar
• Mackenzie KF, Clark K, Naqvi S, McGuire VA, Noehren G, Kristariyanto Y, van den Bosch M, Mudaliar M, McCarthy PC, Pattison MJ, Pedrioli PG, Barton GJ, Toth R, Prescott A, Arthur JS. 2013. PGE2 induces macrophage IL-10 production and a regulatory-like phenotype via a protein kinase A-SIK-CRTC3 pathway. J. Immunol. 190:565–577.
   PubMedGoogle Scholar
• Taylor GA, Carballo E, Lee DM, Lai WS, Thompson MJ, Patel DD, Schenkman DI, Gilkeson GS, Broxmeyer HE, Haynes BF, Blackshear PJ. 1996. A pathogenetic role for TNF alpha in the syndrome of cachexia, arthritis, and autoimmunity resulting from tristetraprolin (TTP) deficiency. Immunity 4:445–454.
   PubMed Web of Science ®Google Scholar
• Arthur JS, Cohen P. 2000. MSK1 is required for CREB phosphorylation in response to mitogens in mouse embryonic stem cells. FEBS Lett. 482:44–48.
   PubMed Web of Science ®Google Scholar
• Wingate AD, Martin KJ, Hunter C, Carr JM, Clacher C, Arthur JS. 2009. Generation of a conditional CREB Ser133Ala knockin mouse. Genesis 47:688–696.
   PubMedGoogle Scholar
• Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. 1993. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75:263–274.
   PubMed Web of Science ®Google Scholar
• Pattison MJ, Mackenzie KF, Arthur JS. 2012. Inhibition of JAKs in macrophages increases lipopolysaccharide-induced cytokine production by blocking IL-10-mediated feedback. J. Immunol. 189:2784–2792.
   PubMed Web of Science ®Google Scholar
• Naqvi S, Macdonald A, McCoy CE, Darragh J, Reith AD, Arthur JS. 2012. Characterization of the cellular action of the MSK inhibitor SB-747651A. Biochem. J. 441:347–357.
   PubMedGoogle Scholar
• Mourey RJ, Burnette BL, Brustkern SJ, Daniels JS, Hirsch JL, Hood WF, Meyers MJ, Mnich SJ, Pierce BS, Saabye MJ, Schindler JF, South SA, Webb EG, Zhang J, Anderson DR. 2010. A benzothiophene inhibitor of mitogen-activated protein kinase-activated protein kinase 2 inhibits tumor necrosis factor alpha production and has oral anti-inflammatory efficacy in acute and chronic models of inflammation. J. Pharmacol. Exp. Ther. 333:797–807.
   PubMed Web of Science ®Google Scholar
• Darragh J, Soloaga A, Beardmore VA, Wingate AD, Wiggin GR, Peggie M, Arthur JS. 2005. MSKs are required for the transcription of the nuclear orphan receptors Nur77, Nurr1 and Nor1 downstream of MAPK signalling. Biochem. J. 390:749–759.
   PubMedGoogle Scholar
• Niiro H, Otsuka T, Tanabe T, Hara S, Kuga S, Nemoto Y, Tanaka Y, Nakashima H, Kitajima S, Abe M, et al. 1995. Inhibition by interleukin-10 of inducible cyclooxygenase expression in lipopolysaccharide-stimulated monocytes: its underlying mechanism in comparison with interleukin-4. Blood 85:3736–3745.
   PubMedGoogle Scholar
• Berg DJ, Zhang J, Lauricella DM, Moore SA. 2001. Il-10 is a central regulator of cyclooxygenase-2 expression and prostaglandin production. J. Immunol. 166:2674–2680.
   PubMedGoogle Scholar
• Sawaoka H, Dixon DA, Oates JA, Boutaud O. 2003. Tristetraprolin binds to the 3′-untranslated region of cyclooxygenase-2 mRNA. A polyadenylation variant in a cancer cell line lacks the binding site. J. Biol. Chem. 278:13928–13935.
   PubMedGoogle Scholar
• Dixon DA, Kaplan CD, McIntyre TM, Zimmerman GA, Prescott SM. 2000. Post-transcriptional control of cyclooxygenase-2 gene expression. The role of the 3′-untranslated region. J. Biol. Chem. 275:11750–11757.
   PubMed Web of Science ®Google Scholar
• Mukhopadhyay D, Houchen CW, Kennedy S, Dieckgraefe BK, Anant S. 2003. Coupled mRNA stabilization and translational silencing of cyclooxygenase-2 by a novel RNA binding protein, CUGBP2. Mol. Cell 11:113–126.
   PubMed Web of Science ®Google Scholar
• Chrestensen CA, Schroeder MJ, Shabanowitz J, Hunt DF, Pelo JW, Worthington MT, Sturgill TW. 2004. MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J. Biol. Chem. 279:10176–10184.
   PubMed Web of Science ®Google Scholar
• Stoecklin G, Stubbs T, Kedersha N, Wax S, Rigby WF, Blackwell TK, Anderson P. 2004. MK2-induced tristetraprolin:14-3-3 complexes prevent stress granule association and ARE-mRNA decay. EMBO J. 23:1313–1324.
   PubMed Web of Science ®Google Scholar
• Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A, Gaestel M. 2006. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol. Cell. Biol. 26:2399–2407.
   PubMed Web of Science ®Google Scholar
• Arthur JS. 2008. MSK activation and physiological roles. Front. Biosci. 13:5866–5879.
   PubMed Web of Science ®Google Scholar
• Soloaga A, Thomson S, Wiggin GR, Rampersaud N, Dyson MH, Hazzalin CA, Mahadevan LC, Arthur JS. 2003. MSK2 and MSK1 mediate the mitogen- and stress-induced phosphorylation of histone H3 and HMG-14. EMBO J. 22:2788–2797.
   PubMed Web of Science ®Google Scholar
• Perez-Cadahia B, Drobic B, Espino PS, He S, Mandal S, Healy S, Davie JR. 2011. Role of mitogen- and stress-activated protein kinase 1 (MSK1) in the malignant phenotype of Ras-transformed mouse fibroblasts. J. Biol. Chem. 286:42–49.
   PubMedGoogle Scholar
• Shibata Y, Nishiyama A, Ohata H, Gabbard J, Myrvik QN, Henriksen RA. 2005. Differential effects of IL-10 on prostaglandin H synthase-2 expression and prostaglandin E2 biosynthesis between spleen and bone marrow macrophages. J. Leukoc. Biol. 77:544–551.
   PubMedGoogle Scholar
• Clark A, Dean J, Tudor C, Saklatvala J. 2009. Post-transcriptional gene regulation by MAP kinases via AU-rich elements. Front. Biosci. 14:847–871.
   Web of Science ®Google Scholar
• Blackshear PJ. 2002. Tristetraprolin and other CCCH tandem zinc-finger proteins in the regulation of mRNA turnover. Biochem. Soc. Trans. 30:945–952.
   PubMed Web of Science ®Google Scholar
• Kratochvill F, Machacek C, Vogl C, Ebner F, Sedlyarov V, Gruber AR, Hartweger H, Vielnascher R, Karaghiosoff M, Rulicke T, Muller M, Hofacker I, Lang R, Kovarik P. 2011. Tristetraprolin-driven regulatory circuit controls quality and timing of mRNA decay in inflammation. Mol. Syst. Biol. 7:560.
   PubMed Web of Science ®Google Scholar
• Marchese FP, Aubareda A, Tudor C, Saklatvala J, Clark AR, Dean JL. 2010. MAPKAP kinase 2 blocks tristetraprolin-directed mRNA decay by inhibiting CAF1 deadenylase recruitment. J. Biol. Chem. 285:27590–27600.
   PubMed Web of Science ®Google Scholar
• Phillips K, Kedersha N, Shen L, Blackshear PJ, Anderson P. 2004. Arthritis suppressor genes TIA-1 and TTP dampen the expression of tumor necrosis factor alpha, cyclooxygenase 2, and inflammatory arthritis. Proc. Natl. Acad. Sci. U. S. A. 101:2011–2016.
   PubMed Web of Science ®Google Scholar
• Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, Clark AR. 2000. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol. Cell. Biol. 20:4265–4274.
   PubMed Web of Science ®Google Scholar
• Fernau NS, Fugmann D, Leyendecker M, Reimann K, Grether-Beck S, Galban S, Ale-Agha N, Krutmann J, Klotz LO. 2010. Role of HuR and p38MAPK in ultraviolet B-induced post-transcriptional regulation of COX-2 expression in the human keratinocyte cell line HaCaT. J. Biol. Chem. 285:3896–3904.
   PubMedGoogle Scholar
• Jin SH, Kim TI, Yang KM, Kim WH. 2007. Thalidomide destabilizes cyclooxygenase-2 mRNA by inhibiting p38 mitogen-activated protein kinase and cytoplasmic shuttling of HuR. Eur. J. Pharmacol. 558:14–20.
   PubMed Web of Science ®Google Scholar
• Lafarga V, Cuadrado A, Lopez de Silanes I, Bengoechea R, Fernandez-Capetillo O, Nebreda AR. 2009. p38 mitogen-activated protein kinase- and HuR-dependent stabilization of p21(Cip1) mRNA mediates the G1/S checkpoint. Mol. Cell. Biol. 29:4341–4351.
   PubMed Web of Science ®Google Scholar
• Sun L, Stoecklin G, Van Way S, Hinkovska-Galcheva V, Guo RF, Anderson P, Shanley TP. 2007. Tristetraprolin (TTP)-14-3-3 complex formation protects TTP from dephosphorylation by protein phosphatase 2a and stabilizes tumor necrosis factor-alpha mRNA. J. Biol. Chem. 282:3766–3777.
   PubMed Web of Science ®Google Scholar
• Clement SL, Scheckel C, Stoecklin G, Lykke-Andersen J. 2011. Phosphorylation of tristetraprolin by MK2 impairs AU-rich element mRNA decay by preventing deadenylase recruitment. Mol. Cell. Biol. 31:256–266.
   PubMed Web of Science ®Google Scholar
• Kontoyiannis D, Kotlyarov A, Carballo E, Alexopoulou L, Blackshear PJ, Gaestel M, Davis R, Flavell R, Kollias G. 2001. Interleukin-10 targets p38 MAPK to modulate ARE-dependent TNF mRNA translation and limit intestinal pathology. EMBO J. 20:3760–3770.
   PubMed Web of Science ®Google Scholar
• Tudor C, Marchese FP, Hitti E, Aubareda A, Rawlinson L, Gaestel M, Blackshear PJ, Clark AR, Saklatvala J, Dean JL. 2009. The p38 MAPK pathway inhibits tristetraprolin-directed decay of interleukin-10 and pro-inflammatory mediator mRNAs in murine macrophages. FEBS Lett. 583:1933–1938.
   PubMedGoogle Scholar
• Gaba A, Grivennikov SI, Do MV, Stumpo DJ, Blackshear PJ, Karin M. 2012. Cutting edge: IL-10-mediated tristetraprolin induction is part of a feedback loop that controls macrophage STAT3 activation and cytokine production. J. Immunol. 189:2089–2093.
   PubMedGoogle Scholar
• Rincon M, Davis RJ. 2009. Regulation of the immune response by stress-activated protein kinases. Immunol. Rev. 228:212–224.
   PubMed Web of Science ®Google Scholar
• Cuadrado A, Nebreda AR. 2010. Mechanisms and functions of p38 MAPK signalling. Biochem. J. 429:403–417.
   PubMed Web of Science ®Google Scholar
• Ajibade AA, Wang Q, Cui J, Zou J, Xia X, Wang M, Tong Y, Hui W, Liu D, Su B, Wang HY, Wang RF. 2012. TAK1 negatively regulates NF-kappaB and p38 MAP kinase activation in Gr-1+CD11b+ neutrophils. Immunity 36:43–54.
   PubMedGoogle Scholar
• Huang Q, Yang J, Lin Y, Walker C, Cheng J, Liu ZG, Su B. 2004. Differential regulation of interleukin 1 receptor and Toll-like receptor signaling by MEKK3. Nat. Immunol. 5:98–103.
   PubMed Web of Science ®Google Scholar
• Matsuzawa A, Saegusa K, Noguchi T, Sadamitsu C, Nishitoh H, Nagai S, Koyasu S, Matsumoto K, Takeda K, Ichijo H. 2005. ROS-dependent activation of the TRAF6-ASK1-p38 pathway is selectively required for TLR4-mediated innate immunity. Nat. Immunol. 6:587–592.
   PubMed Web of Science ®Google Scholar
• Yu L, Min W, He Y, Qin L, Zhang H, Bennett AM, Chen H. 2009. JAK2 and SHP2 reciprocally regulate tyrosine phosphorylation and stability of proapoptotic protein ASK1. J. Biol. Chem. 284:13481–13488.
   PubMedGoogle Scholar